TearsForFears2016-11-08 23:04
$Nevro(NVRO)$ 面是吃了一碗有一碗,但是功课(yao)不能停, 有兴趣的可以对比看看两季cc纪要; 花街也很关心Q4 和澳大利亚的问题以及环比的问题;和我们关心的差不多; 可以肯定的是下个季度盈利应该没有指望了,管理层明确指出要扩大规模;所以我更倾向于下个季度会提高预期;Nevro 应该有这个...查看全文
TearsForFears2016-11-08 08:26
$Nevro(NVRO)$ 有一点我不是很明白, 225M的全年预期是否太保守了,
225M - 61 - 55.4 - 41.65 = 67M 第四个季难道只有区区67M,4季度一般都是医疗的旺季; 这样同比就只有100%的增长了,这样的话就不难解释盘后额下跌了; 虽然对应全年还是有 300%+的增长; 所以我认为Q4应该调高到90M,对应全...查看全文
智通财经APP获悉,鉴于多数大型医疗科技公司已公开表示有意在该领域进行收购,摩根大通分析师Robbie Marcus列出了潜在的收购目标,包括:英特格拉生命科学(IART.US)、Nevro (NVRO.US)、纽瓦索器材(NUVA.US)、Silk Road Medical (SILK.US... 网页链接
$Nevro(NVRO)$ 8-K Current report, item 5.02 Accession Number: 0001193125-24-114307 Act: 34 Size: 138 KB 网页链接
$Nevro(NVRO)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001610717-24-000207 Size: 4 KB 网页链接
$Nevro(NVRO)$ DEF 14A Other definitive proxy statements Accession Number: 0000950170-24-044100 Act: 34 Size: 6 MB 网页链接
$Nevro(NVRO)$ DEFA14A Additional definitive proxy soliciting materials and Rule 14(a)(12) material Accession Number: 0000950170-24-044108 Act: 34 Size: 1 MB 网页链接
$Nevro(NVRO)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001610717-24-000204 Size: 4 KB 网页链接
$Nevro(NVRO)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001610717-24-000200 Size: 4 KB 网页链接
$Nevro(NVRO)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001610717-24-000201 Size: 4 KB 网页链接
$Nevro(NVRO)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001610717-24-000202 Size: 8 KB 网页链接
$Nevro(NVRO)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001610717-24-000203 Size: 4 KB 网页链接
$Nevro(NVRO)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001610717-24-000159 Size: 4 KB 网页链接